![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 30, 15528-15534, 10, 1988
H Takahashi, T Nukiwa, K Satoh, F Ogushi, M Brantly, G Fells, L Stier, M Courtney and RG Crystal
The "deficiency" group of alpha 1-antitrypsin (alpha 1AT) alleles is
characterized by alpha 1AT genes that code for alpha 1AT present in serum
but in amounts insufficient to protect the lower respiratory tract from
progressive destruction by its burden of neutrophil elastase. Mprocida, a
rare alpha 1AT allele associated with alpha 1AT serum levels less than 10
mg/dl (normal 150-350 mg/dl), codes for an alpha 1AT molecule that focuses
on immobilized pH gradient isoelectric gels slightly cathodal to the common
normal M1 (Val213) protein. On a per molecule basis, Mprocida has a mildly
reduced function as an inhibitor, with an association rate constant for
human neutrophil elastase of 7.0 +/- 0.1 x 10(6) M-1 s-1 (normal M1
(Val213) 9.3 +/- 0.8 x 10(6), p less than 0.01). The Mprocida molecule
behaves normally in vivo with a half-life similar to normal M1 alpha 1AT
molecules. Restriction endonuclease mapping demonstrates that the cloned
Mprocida gene was grossly intact. Sequencing of all the exons, exon-intron
junctions, and the major promoter region demonstrated Mprocida to be
identical to the M1 (Val213) gene except for a single base substitution in
exon II coding for amino acid 41 of the mature protein (M1 (Val213) Leu41
CTG----Mprocida Pro41 CCG). Usefully, the coding sequence of the alpha 1AT
residues 40-41 is recognized by the restriction endonuclease PvuII so that
using a probe corresponding to this region of exon II, the Mprocida
mutation can be rapidly identified by Southern analysis. Evaluation of the
crystallographic structure of alpha 1AT suggests the Leu41 to Pro41
mutation may disrupt alpha-helix A in the region of Pro21-Ser45, suggesting
the possibility that the alpha 1AT Mprocida molecule is unstable and
degraded intracellularly prior to secretion.
Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida
Pulmonary Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Prins, B. B. van der Meijden, R. J. Kraaijenhagen, and J. P.M. Wielders Inherited Chronic Obstructive Pulmonary Disease: New Selective-Sequencing Workup for {alpha}1-Antitrypsin Deficiency Identifies 2 Previously Unidentified Null Alleles Clin. Chem., January 1, 2008; 54(1): 101 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Ferrarotti, J Baccheschi, M Zorzetto, C Tinelli, L Corda, B Balbi, I Campo, E Pozzi, G Faa, P Coni, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency J. Med. Genet., March 1, 2005; 42(3): 282 - 287. [Full Text] [PDF] |
||||
![]() |
D L DeMeo and E K Silverman {alpha}1-Antitrypsin deficiency {middle dot} 2: Genetic aspects of {alpha}1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk Thorax, March 1, 2004; 59(3): 259 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Jung, Y.-R. Na, and H. Im Retarded protein folding of deficient human {alpha}1-antitrypsin D256V and L41P variants Protein Sci., March 1, 2004; 13(3): 694 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MASON and R. G. CRYSTAL Pulmonary Cell Biology Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S72 - S81. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |